Petmed Express Inc
NASDAQ:PETS

Watchlist Manager
Petmed Express Inc Logo
Petmed Express Inc
NASDAQ:PETS
Watchlist
Price: 4.97 USD -2.55% Market Closed
Market Cap: 102.7m USD
Have any thoughts about
Petmed Express Inc?
Write Note

Petmed Express Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Petmed Express Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Petmed Express Inc
NASDAQ:PETS
Accrued Liabilities
$30.2m
CAGR 3-Years
81%
CAGR 5-Years
60%
CAGR 10-Years
29%
D
DoorDash Inc
NASDAQ:DASH
Accrued Liabilities
$2.5B
CAGR 3-Years
44%
CAGR 5-Years
111%
CAGR 10-Years
N/A
Chewy Inc
NYSE:CHWY
Accrued Liabilities
$950.1m
CAGR 3-Years
11%
CAGR 5-Years
21%
CAGR 10-Years
N/A
ETSY Inc
NASDAQ:ETSY
Accrued Liabilities
$299m
CAGR 3-Years
10%
CAGR 5-Years
34%
CAGR 10-Years
39%
eBay Inc
NASDAQ:EBAY
Accrued Liabilities
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amazon.com Inc
NASDAQ:AMZN
Accrued Liabilities
$53.6B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
22%
No Stocks Found

Petmed Express Inc
Glance View

Market Cap
102.7m USD
Industry
Retail

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

PETS Intrinsic Value
5.6 USD
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Petmed Express Inc's Accrued Liabilities?
Accrued Liabilities
30.2m USD

Based on the financial report for Sep 30, 2024, Petmed Express Inc's Accrued Liabilities amounts to 30.2m USD.

What is Petmed Express Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
29%

Over the last year, the Accrued Liabilities growth was 158%. The average annual Accrued Liabilities growth rates for Petmed Express Inc have been 81% over the past three years , 60% over the past five years , and 29% over the past ten years .

Back to Top